IOO
Fibro □ Good
) ■ Intermediate
MPNST
ω
Φ
ω
ω
ф
о
о
Ф
≥
ф
ф
' Angio
й—I----)
‘ Synovial
—∣----)
Osteo
—∣----)
' MFH
«—I----)
, Lipo
H—I----)
I Leiomyo
Hj-------I------------)
’ Rhabdo
н—∣------)
Ewings
⅛—I----)
0/13
0/2
6/28
7/29
3/29
5/26
3/20
2/15
1/5
1/12
0.0 0.1 0.2 0.3 0.4 0.5
Success Rates
Figure 4.5: Central 95% credible intervals for the success rates of the treatment in the
sarcoma subtypes in the study when applying the proposed NEPPM with parameter
7 = 1. Right square bracket marks the 5% percentile. The upper two and the rest
CFs correspond, respectively, to the two and ten sarcoma subtypes with good and
intermediate prognoses.